Saxenda® is a glucagon-like peptide-1 (GLP-1) receptor agonist used for weight management in obese or overweight patients with related comorbidities. It acts by reducing appetite, promoting weight loss, and maintaining lower calorie intake. Saxenda® is primarily indicated as an adjunct to diet and physical activity for patients with an initial BMI of 30 kg/m² (obese) or 27 kg/m² (overweight) in the presence of weight-related conditions such as hypertension or type 2 diabetes. It is available as a 6 mg/mL solution in pre-filled syringes and is injected subcutaneously.